DRC3
Dynein regulatory complex subunit 3
Also known as: CFAP134, DKFZP586M1120, DRC3_HUMAN, LRRC48
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H069
- Gene
- DRC3
- Ensembl
- ENSG00000171962
- Chromosome
- 17
- Canonical length
- 523 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Mid piece,Principal piece,End piece
OverviewNCBI Gene
Located in axoneme. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
523 residues, UniProt reviewed canonical sequence.
>Q9H069|DRC3
1 MNQPCNSMEP RVMDDDMLKL AVGDQGPQEE AGQLAKQEGI LFKDVLSLQL DFRNILRIDN
61 LWQFENLRKL QLDNNIIEKI EGLENLAHLV WLDLSFNNIE TIEGLDTLVN LEDLSLFNNR
121 ISKIDSLDAL VKLQVLSLGN NRIDNMMNII YLRRFKCLRT LSLSRNPISE AEDYKMFICA
181 YLPDLMYLDY RRIDDHTKKL AEAKHQYSID ELKHQENLMQ AQLEDEQAQR EELEKHKTAF
241 VEHLNGSFLF DSMYAEDSEG NNLSYLPGVG ELLETYKDKF VIICVNIFEY GLKQQEKRKT
301 ELDTFSECVR EAIQENQEQG KRKIAKFEEK HLSSLSAIRE ELELPNIEKM ILECSADISE
361 LFDALMTLEM QLVEQLEETI NMFERNIVDM VGLFIENVQS LMAQCRDLEN HHHEKLLEIS
421 ISTLEKIVEG DLDEDLPNDL RALFVDKDTI VNAVGASHDI HLLKIDNRED ELVTRINSWC
481 TRLIDRIHKD EIMRNRKRVK EINQYIDHMQ SELDNLECGD ILDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DRC3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 58 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 58 nTPM
- choroid plexus: 25 nTPM
- epididymis: 11 nTPM
- testis: 11 nTPM
- pituitary gland: 8.7 nTPM
- retina: 8.2 nTPM
Single-cell type
- respiratory ciliated cells: 459 nCPM
- fallopian tube ciliated cells: 354 nCPM
- ependymal cells: 311 nCPM
- epididymal efferent duct ciliated cells: 239 nCPM
- endometrial ciliated cells: 206 nCPM
- cone photoreceptor cells: 85 nCPM
Immune cell
- neutrophil: 0.6 nTPM
- eosinophil: 0.5 nTPM
- memory CD8 T-cell: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- myeloid DC: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
Brain region
- choroid plexus: 39 nTPM
- midbrain: 24 nTPM
- medulla oblongata: 20 nTPM
- spinal cord: 15 nTPM
- pons: 9.3 nTPM
- hypothalamus: 8.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.04
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DRC3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DRC3 as an antibody target. Whether an autoantibody or antibody against DRC3 could matter depends on whether native DRC3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DRC3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DRC3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...